Arbutus Biopharma Corp

XNAS:ABUS 4:00:00 PM EDT

4.24

-0.11 (-2.53%)

5:44:16 PM EDT: $4.23 -0.01 (-0.24%)

Market Cap (Intraday)	835.01M
Current PE	5.20
Forward PE	14.13
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.45 Million
Adjusted EPS	-$0.03

See more estimates

10-Day MA	$4.32
50-Day MA	$4.39
200-Day MA	$4.31

See more pivots

Arbutus Biopharma Corp Stock, XNAS:ABUS

701 Veterans Circle, Suite 100, Warminster, Pennsylvania 18974

United States of America

Phone: +1.267.469.0914

Number of Employees: 73

http://www.arbutusbio.com

Description

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.